[NBIX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
03-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -186.07%
YoY- -651.08%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 515,200 498,800 452,700 420,400 412,000 387,900 378,200 22.81%
PBT 198,200 115,600 121,600 -103,300 117,900 97,900 -23,300 -
Tax 50,500 32,500 26,100 -26,700 28,900 29,400 -6,400 -
NP 147,700 83,100 95,500 -76,600 89,000 68,500 -16,900 -
Tax Rate -25.48% -28.11% -21.46% - -24.51% -30.03% - -
Total Cost 367,500 415,700 357,200 497,000 323,000 319,400 395,100 -4.70%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 28.67 16.66 21.10 -18.22 21.60 17.66 -4.47 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 1.50 0.85 0.98 -0.79 0.92 0.72 -0.18 -
EPS Diluted 1.44 0.82 0.95 -0.79 0.88 0.69 -0.18 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.